|
Volumn 25, Issue 8, 2006, Pages 869-879
|
Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report-2006
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CALCINEURIN INHIBITOR;
CYCLOSPORIN;
CYTOKINE RECEPTOR ANTAGONIST;
HLA B ANTIGEN;
HLA DR ANTIGEN;
INTERLEUKIN 2 RECEPTOR BLOCKING AGENT;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
RAPAMYCIN;
TACROLIMUS;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
AGE DISTRIBUTION;
ARTICLE;
CARDIAC ALLOGRAFT VASCULOPATHY;
CARDIAC GRAFT REJECTION;
CARDIOMYOPATHY;
CONGENITAL HEART DISEASE;
CORONARY ARTERY DISEASE;
DEMOGRAPHY;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEART ASSIST DEVICE;
HEART LEFT VENTRICLE;
HEART LUNG TRANSPLANTATION;
HEART TRANSPLANTATION;
HLA MATCHING;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KAPLAN MEIER METHOD;
MEDICAL SOCIETY;
ORGAN DONOR;
PERIOPERATIVE PERIOD;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROPORTIONAL HAZARDS MODEL;
SEX RATIO;
SURVIVAL RATE;
TREATMENT INDICATION;
VALVULAR HEART DISEASE;
ADOLESCENT;
ADULT;
AGED;
CAUSE OF DEATH;
CHILD;
FEMALE;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSION;
INTERNATIONALITY;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
REGISTRIES;
RISK FACTORS;
SURVIVAL RATE;
|
EID: 33746477523
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/j.healun.2006.05.002 Document Type: Article |
Times cited : (303)
|
References (5)
|